US Stocks
/
Aquestive Therapeutics, Inc. Share Price
Aquestive Therapeutics, Inc. Share Price

Aquestive Therapeutics, Inc. Share Price

NASDAQ: AQST | Small Cap
$4.76
+0.00 (0.00%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aquestive Therapeutics, Inc. Stock Performance

Open
$4.80
Prev. Close
$4.76
Circuit Range
N/A
Day Range
$4.75 - $4.97
Year Range
$2.93 - $7.54
Volume
1,48,192
Average Traded
$4.83

Aquestive Therapeutics, Inc. Share Price Today

As of 11 October 2026, Aquestive Therapeutics, Inc.'s share price is $4.76. The stock opened at $4.80, compared to its previous close of $4.76. During today's trading session, Aquestive Therapeutics, Inc.'s share price traded between $4.75 and $4.97, with an average price of $4.86. Over the past 52 weeks, the stock has recorded a high of $7.54 and a low of $2.93. In terms of performance, Aquestive Therapeutics, Inc.'s share price has risen by 16.08% over the last six months and is down 30.03% on a year-on-year basis.

Aquestive Therapeutics, Inc. Share Price Chart

$4.75$4.97
L
Show Current Price
H

Aquestive Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$509.50M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.62
Revenue (TTM)
$44.55B
Return On Equity (TTM)
138.24%
Profit Margin
-188.06%
Debt to Equity
-0.90
Quarterly Earnings Growth YoY
-47.96%

Aquestive Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$12.81$13.02$14.45$13.82
Net Profit-$15.45-$31.86-$8.06-$22.86
Net Profit Margin-120.61%-244.70%-55.78%-165.41%
Income ChangeN/A-106.21%74.70%-183.62%

Aquestive Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$47.68$50.58$57.56$44.55
Net Profit-$54.41-$7.87-$44.14-$83.78
Net Profit Margin-114.11%-15.56%-76.69%-188.06%
Income ChangeN/A85.54%-460.86%-89.81%

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Aquestive Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.60
$4.78
+3.35%
Sep 2026
$5.13
$4.63
-10.11%
Aug 2026
$3.67
$5.14
+39.05%
Jul 2026
$4.26
$3.70
-11.38%
Jun 2026
$3.99
$4.17
+3.60%
May 2026
$4.13
$4.03
-1.83%
Apr 2026
$4.19
$4.11
-1.08%
Mar 2026
$4.02
$4.15
+2.98%
Feb 2026
$4.00
$4.03
+37.54%
Jan 2026
$6.57
$2.93
-54.57%
Dec 2025
$6.07
$6.45
+4.12%
Nov 2025
$6.69
$6.20
-9.03%

AQST Share Price FAQs

What is Aquestive Therapeutics, Inc. share price today?

chevron-up
Aquestive Therapeutics, Inc. share price today is $4.76 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Aquestive Therapeutics, Inc. stock?

chevron-up
The 52 week high of Aquestive Therapeutics, Inc. stock is $7.54, while the 52 week low is $2.93 as of 10 Oct '26.

What is AQST's market capitalisation today?

chevron-up
AQST market capitalisation is $509.50M as of October 11, 2026, at 12:26 am IST.

What is AQST's net income for the last quarter?

chevron-up
AQST's net income for the last quarter is -22.86B USD.

What is the 5 year returns of AQST?

chevron-up
The 5 year returns of AQST is -7.39% as on 10 Oct '26.

What is the high & low stock price of AQST today?

chevron-up
AQST stock price hit a high of $4.97 and low of $4.75 as of 10 Oct '26.

Can I buy AQST shares in India?

chevron-up
Yes. You can buy AQST in India by opening an international trading account.